Company: MDCXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001062993-25-013078
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-07-23
Form: 424B3
Chunk 4
---
 |     | Against |     | Abstain |     | Broker Non-Votes |
| 10,063,947 |     |  68,728 |     | N/A     |     |        3,185,015 |

Proposal 5. Shareholders approved the proposal to amend the Articles to increase the voting threshold required to remove the Chairman of the Board to a vote of at least 75% of the Board and to make this provision part of the Articles, which required the affirmative vote of at least two-thirds of the votes cast by the shareholders present at the Meeting in person or by proxy:

| For       |     | Against |     | Abstain |     | Broker Non-Votes |
| 9,891,337 |     | 241,338 |     | N/A     |     |        3,185,015 |

<div align='center'>SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

Dated: July 23, 2025